Golden
Cyrus Biotechnology

Cyrus Biotechnology

Biotechnology software company offering protein modelling and design capabilities.

Cyrus Biotechnology is a privately held company based in Seattle, Washington. It offers protein modeling and design capabilities to the biotechnology, pharmaceutical, chemical, consumer products, and synthetic biology industries. The company's primary product is Cyrus Bench, a software package based on Rosetta, a protein-modeling platform created at the University of Washington.



This Software-as-a-Service (SaaS) product is a platform for protein structure prediction via homology modeling, protein modeling, protein stabilization, protein engineering, and protein design for biologics and small molecules. In July 2018, Cyrus announced that it would release a new immune screening and prediction tool in the platform.



The company's clients include 10 of the top 20 Global Pharmaceutical firms as well as several smaller biotechnology and chemical firms. Cyrus is financed by several technology and biotechnology investors, including Trinity Ventures, Orbimed, Springrock Ventures, Alexandria Venture Investments, the W Fund, and more.

Timeline

July 2017

Cyrus Biotechnology raises a $8,000,000 series A round from W Fund, Trinity Ventures, OrbiMed Advisors, Springrock Ventures and OrbiMed.

Funding rounds

Funding round
Funding round amount (USD)
Funding type
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Alok Chanani

Investor



Benjamin Baker

Employee



Bryden Robertson

Employee



Craig W Philips

Investor



David Baker

Scientific Co-Founder & Advisor



David Pearlman

Director of Customer Experience and Senior Fellow



Gaige Pierce-Raison

Employee



Jake Litwicki

VP of Engineering



Javier Castellanos

Founder & Chief Technical Officer



Lucas Nivon

Founder & CEO



Mary Larrousse

Employee



Michael Monu

Investor



Peter Novotnak

Employee



Rosario Caltabiano

Executive VP of Sales



Ryan Gomoto

Employee



Steven Lewis

Employee



Yifan Song

Founder & Chief Scientific Officer



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









News

Title
Author
Date
Publisher
Description
December 3, 2019
news.yahoo.com
Seattle-based Cyrus Biotechnology says it'll collaborate with the Broad Institute of MIT and Harvard on ways to optimize CRISPR gene-editing techniques for use in developing novel human therapeutics. CRISPR has revolutionized genetics by making it easier to modify the DNA coding in the genome, but

References